Search research articles
Contact Us
Filters
Showing results (21-30 of 194) with videos related to
Page
of 20
Sort By:
European Journal of Gastroenterology & Hepatology
|
September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice
Sailish Honap, Peter M Irving, Mark A Samaan
Gut
|
February 21, 2020
New role for azathioprine in case of switching anti-TNFs in IBD
Konstantinos Papamichael, Adam S Cheifetz, Peter M Irving
Journal of Crohn'S & Colitis
|
August 12, 2022
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis
Sailish Honap, Peter M Irving, Mark A Samaan
Gut
|
November 20, 2020
COVID-19 and IBD drugs: should we change anything at the moment?
Charlie W Lees, Peter M Irving, Laurent Beaugerie
Journal of Crohn'S & Colitis
|
June 14, 2021
Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'
Sailish Honap, Peter M Irving, Nicholas A Kennedy
Alimentary Pharmacology & Therapeutics
|
July 31, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?
Mark A Samaan, Nick Powell, Peter M Irving
The American Journal of Gastroenterology
|
December 14, 2007
Drug interactions in inflammatory bowel disease
Peter M Irving, Fergus Shanahan, David S Rampton
Alimentary Pharmacology & Therapeutics
|
August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitis
Peter M Irving, Yvette Leung, Marla C Dubinsky
World Journal of Gastroenterology
|
November 4, 2015
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
Mark G Ward, Peter M Irving, Miles P Sparrow
Digestive Diseases and Sciences
|
August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?
Robin J Dart, Peter M Irving, Mark A Samaan
Page
of 20
Search research articles
Search
Showing results (21-30 of 194) with videos related to
Sort By:
Page
of 20
European Journal of Gastroenterology & Hepatology
|
September 19, 2023
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice
Sailish Honap, Peter M Irving, Mark A Samaan
Gut
|
February 21, 2020
New role for azathioprine in case of switching anti-TNFs in IBD
Konstantinos Papamichael, Adam S Cheifetz, Peter M Irving
Journal of Crohn'S & Colitis
|
August 12, 2022
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis
Sailish Honap, Peter M Irving, Mark A Samaan
Gut
|
November 20, 2020
COVID-19 and IBD drugs: should we change anything at the moment?
Charlie W Lees, Peter M Irving, Laurent Beaugerie
Journal of Crohn'S & Colitis
|
June 14, 2021
Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'
Sailish Honap, Peter M Irving, Nicholas A Kennedy
Alimentary Pharmacology & Therapeutics
|
July 31, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?
Mark A Samaan, Nick Powell, Peter M Irving
The American Journal of Gastroenterology
|
December 14, 2007
Drug interactions in inflammatory bowel disease
Peter M Irving, Fergus Shanahan, David S Rampton
Alimentary Pharmacology & Therapeutics
|
August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitis
Peter M Irving, Yvette Leung, Marla C Dubinsky
World Journal of Gastroenterology
|
November 4, 2015
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
Mark G Ward, Peter M Irving, Miles P Sparrow
Digestive Diseases and Sciences
|
August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?
Robin J Dart, Peter M Irving, Mark A Samaan
Page
of 20